SCHEMBL7265100

SCHEMBL7265100

O=C(O)[C@H](Cc1ccccc1)NN1C(=O)c2ccccc2C1=O

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.56
▸ GAA P10253 1/20 0.56
▸ L3MBTL1 Q9Y468 3/20 0.53
▸ MEN1 O00255 1/20 0.53
▸ KMT2A Q03164 1/20 0.53
▸ POLB P06746 2/20 0.50
▸ MME P08473 2/20 0.48
▸ TDP1 Q9NUW8 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ FPR2 P25090 2/20 0.46
▸ ALOX15 P16050 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ NAALAD2 Q9Y3Q0 1/20 0.46
▸ MMP2 P08253 1/20 0.44
▸ MMP9 P14780 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7272751 1.00 ALDH1A1 (0.56) ALDH1A1GAAL3MBTL1MEN1KMT2A
SCHEMBL8787955 0.89 ALDH1A1 (0.47) ALDH1A1GAAL3MBTL1MEN1KMT2A
SCHEMBL8106811 0.88 ALDH1A1 (0.58) ALDH1A1GAAL3MBTL1MEN1KMT2A
SCHEMBL8787182 0.88 ALDH1A1 (0.50) ALDH1A1GAAL3MBTL1MEN1KMT2A
SCHEMBL27544391 0.88 ALDH1A1 (0.58) ALDH1A1GAAL3MBTL1MEN1KMT2A
SCHEMBL8787113 0.87 ALDH1A1 (0.49) ALDH1A1GAAL3MBTL1MEN1KMT2A
SCHEMBL29024434 0.86 MME (0.49) L3MBTL1MMENPSR1FPR2NAALAD2
SCHEMBL7301260 0.85 MME (0.44) ALDH1A1GAAL3MBTL1MEN1KMT2A
SCHEMBL11360473 0.83 ALDH1A1 (0.47) ALDH1A1GAAL3MBTL1MEN1KMT2A
SCHEMBL3505431 0.81 ALDH1A1 (0.43) ALDH1A1GAAL3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729456-B1 NOVEL PROCESS FOR PREPARING (S)-1-[2(S)-(1,3-DIHYDRO-1,3-DIOXO-ISOINDOL-2-YL)-1-OXO-3-PHENYLPROPYL]-1,2,3,4-TETRAHYDRO-2-PYRIDINE-CARBOXYLIC ACID METHYL ESTER AND INTERMEDIATES THEREOF MERRELL PHARMA INC (US) 1997-12-17 — — EP claimed
EP-0729456-A1 NOVEL PROCESS FOR PREPARING (S)-1-[2(S)-(1,3-DIHYDRO-1,3-DIOXO-ISOINDOL-2-YL)-1-OXO-3-PHENYLPROPYL]-1,2,3,4-TETRAHYDRO-2-PYRIDINE-CARBOXYLIC ACID METHYL ESTER AND INTERMEDIATES THEREOF MERRELL PHARMACEUTICALS INC. (US) 1996-09-04 — — EP claimed
US-5508411-A Process for preparing (S)-1-[2(S)-(1,3-dihyrdro-1,3-dioxo-isoindo-2-yl)-1-oxo-3-phenylpropyl]-1,2,3,4,-tetrahydro-2-pyridine-carboxylic acid methyl ester MERRELL PHARMACEUTICALS INC. 1996-04-16 — — US claimed
WO-1995014663-A2 NOVEL PROCESS FOR PREPARING (S)-1-[2(S)-(1,3-DIHYDRO-1,3-DIOXO-ISOINDO-2-YL)-1-OXO-3-PHENYLPROPYL]-1,2,3,4-TETRAHYDRO-2-PYRIDINE-CARBOXYLIC ACID METHYL ESTER AND INTERMEDIATES THEREOF MERRELL PHARMACEUTICALS INC. (US) 1995-06-01 — — WO claimed
US-5990341-A Diastereoselective synthesis hydroxyethylene dipeptide isosteres EMORY UNIVERSITY (US) 1999-11-23 — — US disclosed
EP-0729456-B1 NOVEL PROCESS FOR PREPARING (S)-1-[2(S)-(1,3-DIHYDRO-1,3-DIOXO-ISOINDOL-2-YL)-1-OXO-3-PHENYLPROPYL]-1,2,3,4-TETRAHYDRO-2-PYRIDINE-CARBOXYLIC ACID METHYL ESTER AND INTERMEDIATES THEREOF MERRELL PHARMA INC (US) 1997-12-17 — — EP disclosed
US-5587514-A Diastereoselective synthesis of hydroxyethylene dipeptide isosteres EMORY UNIVERSITY (US) 1996-12-24 — — US disclosed
EP-0729456-A1 NOVEL PROCESS FOR PREPARING (S)-1-[2(S)-(1,3-DIHYDRO-1,3-DIOXO-ISOINDOL-2-YL)-1-OXO-3-PHENYLPROPYL]-1,2,3,4-TETRAHYDRO-2-PYRIDINE-CARBOXYLIC ACID METHYL ESTER AND INTERMEDIATES THEREOF MERRELL PHARMACEUTICALS INC. (US) 1996-09-04 — — EP disclosed
US-5508411-A Process for preparing (S)-1-[2(S)-(1,3-dihyrdro-1,3-dioxo-isoindo-2-yl)-1-oxo-3-phenylpropyl]-1,2,3,4,-tetrahydro-2-pyridine-carboxylic acid methyl ester MERRELL PHARMACEUTICALS INC. 1996-04-16 — — US disclosed
US-5502253-A Cyclohex-2-enyl acetamides MERRELL PHARMACEUTICALS INC. 1996-03-26 — — US disclosed
WO-1995014655-A1 DIASTEREOSELECTIVE SYNTHESIS OF HYDROXYETHYLENE DIPEPTIDE ISOSTERES EMORY UNIVERSITY (US) 1995-06-01 — — WO disclosed
WO-1995014663-A2 NOVEL PROCESS FOR PREPARING (S)-1-[2(S)-(1,3-DIHYDRO-1,3-DIOXO-ISOINDO-2-YL)-1-OXO-3-PHENYLPROPYL]-1,2,3,4-TETRAHYDRO-2-PYRIDINE-CARBOXYLIC ACID METHYL ESTER AND INTERMEDIATES THEREOF MERRELL PHARMACEUTICALS INC. (US) 1995-06-01 — — WO disclosed
EP-0322914-B1 Novel sulfhydryl containing tricyclic lactams and their pharmacological methods of use MERRELL DOW PHARMA (US) 1994-01-19 — — EP disclosed
EP-0249223-B1 NOVEL ANTIHYPERTENSIVE AGENT MERRELL DOW PHARMACEUTICALS INC. (US) 1992-10-14 — — EP disclosed
US-5095110-A Process for the preparation of sulfhydryl containing tricyclic lactams MERRELL DOW PHARMACEUTICALS INC. (US) 1992-03-10 — — US disclosed
US-4973585-A INHIBITORS OF ANGIOTENSIN CONVERTING ENZYME MERRELL DOW PHARMACEUTICALS (US) 1990-11-27 — — US disclosed
CN-1034721-A New tricyclic lactam that contains sulfydryl and the method for on pharmacology, using thereof MERRELL DOW PHARMA (US) 1989-08-16 — — CN disclosed
EP-0322914-A2 Novel sulfhydryl containing tricyclic lactams and their pharmacological methods of use MERRELL DOW PHARMACEUTICALS INC. (US) 1989-07-05 — — EP disclosed
US-4824832-A INHIBIT ANGIOTENSIN CONVERTING ENZYME MERRELL DOW PHARMACEUTICALS INC. (US) 1989-04-25 — — US disclosed
EP-0249223-A2 Novel antihypertensive agent MERRELL DOW PHARMACEUTICALS INC. (US) 1987-12-16 — — EP disclosed
Send feedback